Title:
HETEROCYCLIC PYRIMIDINE COMPOUND, PHARMACEUTICAL COMPOSITION AND APPLICATION THEREOF
Document Type and Number:
WIPO Patent Application WO/2024/078436
Kind Code:
A1
Abstract:
The present disclosure discloses a compound having formula (I) or a pharmaceutically acceptable salt thereof which acts as a USP1 inhibitor, a pharmaceutical composition comprising the compound or the pharmaceutically acceptable salt thereof, and a use thereof in the prevention or treatment of diseases mediated by USP1.
Inventors:
ZHU WEI (CN)
SUN TIANWEN (CN)
GAO DONGLIN (CN)
WANG TAO (CN)
CHEN XIANG (CN)
LI ZHENGTAO (CN)
SUN TIANWEN (CN)
GAO DONGLIN (CN)
WANG TAO (CN)
CHEN XIANG (CN)
LI ZHENGTAO (CN)
Application Number:
PCT/CN2023/123495
Publication Date:
April 18, 2024
Filing Date:
October 09, 2023
Export Citation:
Assignee:
HAINAN SIMCERE ZAIMING PHARMACEUTICAL CO LTD (CN)
International Classes:
C07D487/10; A61K31/519; A61P35/00; C07D417/14; C07D487/04; C07D519/00
Domestic Patent References:
| WO2023148643A1 | 2023-08-10 | |||
| WO2022214053A1 | 2022-10-13 | |||
| WO2022216820A1 | 2022-10-13 | |||
| WO2023083297A1 | 2023-05-19 | |||
| WO2022199652A1 | 2022-09-29 |
Foreign References:
| CN116462679A | 2023-07-21 | |||
| CN116496252A | 2023-07-28 | |||
| CN113164485A | 2021-07-23 | |||
| CN108473495A | 2018-08-31 | |||
| CN113474346A | 2021-10-01 |
Download PDF: